Literature DB >> 32307738

Expiratory variability index (EVI) is associated with the severity of acute bronchial obstruction in small children: a proof of concept study.

Ville-Pekka Seppä1, Mirjana Turkalj2,3,4, Anton Hult1, Ivana Maloča Vuljanko5, Davor Plavec4,6, Damir Erceg2,3,4, Giorgije Petković5.   

Abstract

BACKGROUND: Lung function testing in small children is cumbersome. However, reduced variability of tidal breathing recorded using impedance pneumography (IP) during sleep was recently found to be a potential objective marker of wheeze in children aged 1-5 years. We aimed to investigate how an acute bronchial obstruction (BO) and its severity, and recovery thereof reflects in expiratory variability index (EVI).
METHODS: EVI was measured using a wearable IP system (Ventica®) during sleep in 40 healthy controls (aged 1.5-5.9 y) and 30 patients hospitalised due to acute BO (aged 1.3-5.3 y). In healthy controls EVI was measured for 1-3 nights at their homes. Patients were measured for several nights during hospitalisation, as practically feasible, and at home 2 and 4 weeks post-discharge.
RESULTS: We received 79 EVI results from 39 controls and 139 from 30 patients. 90 % had previous BO episodes, 30 % used asthma controller medication before and 100 % after hospitalisation. Compared to controls, EVI was significantly lower during hospitalisation (p<0.0001) having significant correlation with number of days to discharge (r=-0.38, p=0.004). At 2 or 4 weeks post-discharge, EVI was not significantly different from the controls (p=0.14, p=0.49, respectively). EVI was significantly associated with chest auscultation findings (p=0.0001) being 17.5 (4.9) (median, IQR) with normal auscultation, 15.6 (7.4) in those with prolonged expiration, and 11.4 (6.8) in those with wheeze and/or rales and crackles.
CONCLUSIONS: EVI was found to be a sensitive, objective marker of acute BO, showing strong association with changes in clinical status in wheezy children aged 1-5 years. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2020        PMID: 32307738     DOI: 10.1111/pai.13257

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  1 in total

1.  Observational study of inhaled corticosteroid treatment for improved expiratory variability index in steroid-naïve asthmatic children.

Authors:  Janne Burman; Pekka Malmberg; Ville-Pekka Seppä; Tuomas Jartti; Sami Remes; Ove Mickelsson; Anna S Pelkonen; Mika J Mäkelä
Journal:  ERJ Open Res       Date:  2021-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.